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The forebrain is the seat of higher-order brain functions, andmany human neuropsychiatric disorders are due
to genetic defects affecting forebrain development, making it imperative to understand the underlying
genetic circuitry. Recent progress now makes it possible to begin fully elucidating the genomic regulatory
mechanisms that control forebrain gene expression. Herein, we discuss the current knowledge of how
transcription factors drive gene expression programs through their interactions with cis-acting genomic
elements, such as enhancers; how analyses of chromatin and DNA modifications provide insights into
gene expression states; and how these approaches yield insights into the evolution of the human brain.Overview
Working at the turn of the twentieth century, Santiago Ramo´n y
Cajal demonstrated the variety of neuronal cell types and pro-
vided insights into the network of connections within the brain
using simple histological stains and light microscopes (Cajal,
1899). Over 100 years later, despite the availability of advanced
imaging, and molecular and functional analysis tools, much re-
mains unknown about the genetic factors controlling the devel-
opment, structure, and function of the intricate features that, in
their entirety, form the human central nervous system. The fore-
brain houses the neural structures that control higher-order brain
functions, including the pallium (cortex and hippocampus),
subpallium (striatum, pallidum, preoptic area, and septum), hy-
pothalamus, and thalamus. Understanding the development,
evolution, function, and dysfunction of the forebrain requires a
deep understanding of the genetic control of how its compo-
nents are assembled and interconnected.
At the core of the processes that regulate forebrain develop-
ment and function is the transcriptional circuitry. Over the past
25 years, numerous regional and cell type-specific transcription
factors (TFs) have been identified and characterized.We are now
aware of some components of TF networks that control region-
alizationwithin the embryonic brain. Although general paradigms
for identifying TFs and defining their cellular functions have been
established, studies are now needed to explore and understand
the molecular and genomic mechanisms through which net-
works of such TFs function during development. Of paramount
importance is elucidating the cis-regulatory genomic elements
where sets of TFs interact to control forebrain gene expression.
Recent technological advances, highlighted by the invention
and application of chromatin immunoprecipitation (ChIP)-based
and high-throughput sequencing assays, have enabled large-
scale efforts to functionally annotate the genome. The results
from studies that have applied these technologies to the devel-
oping brain reveal the essential role of neuronal TFs, the dynamicgene expression landscapes in brain development, and the
extensive role of noncoding regulatory elements. These findings
point to complex regulatory systems underlying the diversifica-
tion of neuronal cell types and structural connectivity that Cajal
drew in his formative illustrations. While many of the details of
the emerging regulatory landscape of the brain remain to be
explored, recent advances highlight the role of transcriptional
control in normal development and in neurological disorders
and disease. In this review, we describe the interplay between
TFs, distal transcriptional enhancers, chromatin structure and
epigenomic features, and DNA-binding and chromatin remodel-
ing proteins in establishing the regulatory circuitry underlying
transcriptional control and development of the forebrain. In
addition, we describe approaches for the identification and char-
acterization of enhancers and other regulatory elements and
provide a perspective on emerging and exciting research on
the genomic and regulatory control of forebrain development,
evolution, and disease.
Annotating Regulatory Elements Active in Forebrain
Development
Metazoan Gene Regulation via cis-Regulatory Elements
Cis-regulatory control of gene expression during development is
a complex process, dependent on distal sequences, spatial or-
ganization of the chromosome, and chromatin or epigenetic
state (Figure 1A). For some genes, notably housekeeping genes,
the proximal regulatory sequence is sufficient for correctly acti-
vating transcription (Lenhard et al., 2012). In contrast, genes
with complex expression patterns can be acted on by many
distal transcriptional enhancers located in intronic, intergenic,
and even exonic sequence, with enhancers potentially located
far from target genes. Enhancers appear to be the most nu-
merous regulatory elements in mammalian genomes and exhibit
extensive tissue and stage specificity, suggesting that distal en-
hancers are required for the precise control of gene expressionNeuron 85, January 7, 2015 ª2015 Elsevier Inc. 27
Figure 1. Types of Gene Regulatory Sequences and
Methods for Their Discovery and Characterization
(A) Schematic view of different chromatin states in genic and
intergenic regions, with characteristic classes of epigenomic
features and an overview of selected methods for their
genome-wide mapping.
(B) Track-style view of features commonly associated with
different types of regulatory sequences.
(C) Transgenic reporter assays enable the validation and
detailed characterization of enhancer activity patterns
in vitro and in vivo.
(D) Massive parallel reporter assays enable medium- and
large-scale function-based enhancer discovery screens.
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Review(ENCODE Project Consortium, 2012; Stamatoyannopoulos
et al., 2012; Nord et al., 2013; Shen et al., 2012). With the binding
of activating TFs, enhancers are brought within spatial proximity
of target promoters through the formation of loops in DNA (Ku-
laeva et al., 2012), with structural proteins such as mediator
and cohesin involved in this process (Kagey et al., 2010). It is
now clear that enhancers may interact with multiple promoters,
and clusters of coregulated genes may exhibit promoter interac-
tions, with the spatial aspects of gene regulation just now begin-
ning to be characterized (Zhang et al., 2013). Many of the details
regarding the mechanisms and timing of transcriptional control
via regulatory sequences remain uncertain. There is evidence
that enhancer-promoter looping may actually be very stable
and not reflect activation (DeMare et al., 2013; Kieffer-Kwon
et al., 2013). Additional classes of regulatory sequences are
also important in gene regulation, such as insulators and si-
lencers (Cuddapah et al., 2009). Significant progress in charac-
terizing the complexity of noncoding regulatory circuitry has
been made in model systems (Lagha et al., 2012), and in specific
lineages and developmental loci (Montavon et al., 2011; Stama-
toyannopoulos, 2005). It is increasingly recognized that tran-
scriptional regulation is achieved endogenously through a
complex interplay of cues that involve the binding of activating
and repressive TFs, chromatin state and structure, epigenomic
modifications and chromatin remodeling proteins, the activity
of long noncoding RNAs, and cis-regulatory elements that can
have activating or repressing function depending on develop-
mental context. Despite this complexity, new technologies
have enabled the identification and characterization of hundreds
of thousands of candidate regulatory elements in the human and
mouse genomes.
Early Approaches to Enhancer Identification in the Brain
Before the publication of the human and mouse reference
genome sequences, regulatory regions were typically found via
trial and error, such as through deconstructing BACs or other
large sequence fragments to determine subregions that con-
trolled expression patterns of target genes. The first genome-
wide predictions of regulatory elements were based on the pres-
ence of evolutionary sequence conservation (homology across
species) or constraint (relative local sequence conservation
across evolution) (Cooper et al., 2005; Frazer et al., 2004; Ovchar-
enko et al., 2004; Prabhakar et al., 2006b; Schwartz et al., 2000;
Siepel et al., 2005) coupled to functional screening via reporter
assays (Kothary et al., 1989; Nobrega et al., 2003; Pennacchio
et al., 2006). The combination of trial and error and comparative
genomics-guided screens, when applied to individual loci of in-
terest, led to the identification of regulatory elements with activity
in the developing forebrain near genes including Arx, Dach1,
Dlx1/2, Dlx5/6, Emx2, Fezf2,Meis1,Otx1/2, Pax6, and Sox2 (Ahi-
tuv et al., 2007; Colasante et al., 2008; Ghanem et al., 2007; Kam-
mandel et al., 1999; Kurokawa et al., 2004, 2014; Machon et al.,
2002; Mariani et al., 2012; Royo et al., 2012; Shim et al., 2012;
Suda et al., 2010; Theil et al., 2002; Zerucha et al., 2000) These
elegant and labor-intensive studies provided first insights into
the regulatory architecture of these key developmental loci. How-
ever, due to the required effort they were limited in the scope of
genomic regions covered and likely missed additional regulatory
elements, particularly those far from the genes of interest or lack-ing strong cross-species conservation. Many additional em-
bryonic brain enhancers have been identified via large-scale
unguided genome-wide screens of extremely conserved non-
coding regions for sequences that drive reporter gene expression
at specific embryonic time points, with the results available in the
VISTA enhancer database (Visel et al., 2007). This database con-
tains over 2,100 tested human andmouse sequences, over 1,100
of which function as enhancers in vivo in embryonic mouse tis-
sues with whole-mount staining images available. The VISTA
enhancer set includes over 350 annotated to drive expression
in the forebrain at embryonic day 11.5 (E11.5), and 147 of these
enhancers additionally include high-resolution images of devel-
opmental brain sections that can be used to map the spatial ac-
tivity of forebrain enhancers (Visel et al., 2013).
Epigenomic Approaches to Study Gene Regulation
Two parallel developments have resulted in rapid expansion of
the catalog of regulatory elements in mammalian genomes and
in annotation of their function. The first is the availability of next-
generation sequencing technologies that cost-effectively ge-
nerate enough sequence coverage to enable genome-wide
enrichmentmaps in a single experiment. The second is the knowl-
edge about interpreting epigenomic marks that emerged from
early studies in the area of cellular and chromatin biology, with
additional traction from ENCODE pilot studies (Birney et al.,,
2007). Current proxy signatures of regulatory element activity
and chromatin state include coactivator binding (e.g., p300), his-
tone modifications, binding of TFs or other DNA-associated pro-
teins, chromatin accessibility, DNA methylation, and nongenic
RNA transcription (Figures 1A and 1B). Using approaches to
assay these signals, it is possible to identify and differentiate clas-
ses of regulatory elements and thus to identify enhancers that are
active in particular cell lines or tissues. There are also emerging
genome-scale tools to map interactions between regulatory se-
quences and their target genes (e.g., ChIA-PET; Fullwood et al.,
2009) and for generating genome-wide interaction maps (e.g.,
chromosome capture assays such as HiC; Lieberman-Aiden
et al., 2009). There is support for sequential chromatin modifi-
cations that are associated with repressed, poised, and active
enhancers (Creyghton et al., 2010; Rada-Iglesias et al., 2011).
For example, the histone modification H3K27me3, shown in
Figure 2B, can be indicative of a repressed region whereas
H3K27ac can indicate active enhancers (Creyghton et al., 2010;
Rada-Iglesias et al., 2011). Despite the general correlation be-
tween specific chromatin modification patterns and activity
states, no specific signatures that have been reported appear to
capture function exactly (Cotney et al., 2012; Visel et al., 2009b).
Although the resources generated by large-scale centralized
efforts, such as the ENCODE and Epigenomics Roadmap initia-
tives, have significantly advanced our understanding of cis-reg-
ulatory elements, there are limitations in using these data sets to
characterize regulatory elements active in the developing brain
due to the incomplete representation of representative cell lines
and tissue types. Nonetheless, application of functional geno-
mics to identify regulatory circuits controlling brain function
has already produced major insights. There are now many
publicly available genomic data sets relevant to the developing
brain (see Table 1 for a partial list). These resources can be of
tremendous value to researchers. For example, the BrainspanNeuron 85, January 7, 2015 ª2015 Elsevier Inc. 29
Figure 2. TFs with Known Roles in Forebrain Development
(A and B)Models of transcriptional pathways in the developingmouse basal ganglia based on RNA expression analyses in the embryonic brain of loss-of-function
TF mutants. Green arrows, activation; red stop signal, repression.
(A) Pathways in the caudal, lateral, and medial ganglionic eminences (CGE, LGE, MGE) based on data in references in main text.
(B) Pathways in the medial ganglionic eminence (MGE) based on data in references in main text.
(C) Expression of TFs in the basal ganglia ofGsx2/, Dlx1/Dlx2/, andGsx2/Dlx1/Dlx2/mutant mice. Expression changes are reported separately for
two different developmental stages (E12.5 and E15.5) in the ventricular zone (VZ), subventricular zone (SVZ), and mantle zone (MZ) of the CGE, LGE, MGE, and
Septum. Colors indicate the effect of each mutation on TF expression: black or no square, not analyzed; gray, no obvious expression change in mutant; white, no
detectable expression; magenta, severe reduction in expression; orange, moderate/mild reduction in expression; green, ectopic expression; blue, increased
expression. In diagonally divided boxes, the top part represents the dorsal region and the bottom the ventral region. Modified from Wang et al. (2013).
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expression networks of genes perturbed in autism and schizo-
phrenia (Gulsuner et al., 2013; Parikshak et al., 2013; Willsey
et al., 2013).
Functional Characterization of Enhancer Activity
in the Brain
Although a number of epigenomic markers, signatures, and as-
says are now available to predict the genomic location of en-
hancers, a continued major challenge is validation of functional
predictions and determination of the exact activity of noncoding30 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.sequences. Reporter-based enhancer assays (Kothary et al.,
1989) have been used extensively to map enhancer activity of
both human and mouse regulatory sequences in vivo, and have
been extended via library-based screening to examine hundreds
to thousands of sequences in parallel. In comparison to assays
performed in cell lines, in vivo functional enhancer analyses
reveal specific cell types, tissue subregions, and developmental
stages at which an enhancer drives expression (Pennacchio
et al., 2006; Visel et al., 2013). Enhancer assays further differ in
how the DNA is delivered, the size of fragment that is introduced,
Table 1. Functional Genomics Data Sets Relevant to Gene Regulation in the Developing Brain
Resource Name URL Description
Genomic Data Sets Focusing on the Brain
Allen brain atlas http://www.brain-map.org developmental transcriptomes, microarray, and
in situ hybridization
Brainspan http://www.brainspan.org mouse and human developmental brain gene expression
MethylomeDB http://www.neuroepigenomics.org/methylomedb mouse and human brain methylome data sets
Nord et al., 2013 http://enhancer.lbl.gov/mouse_time course mouse forebrain developmental H3K27ac data sets
Brain Expression Resources (In Situ, Enhancer, BAC)
VISTA http://enhancer.lbl.gov whole-mount E11.5 mouse activity data for human/mouse
enhancers
Gensat http://www.gensat.org/index.html BAC-driven reporter assays/mice and in situ data
Large-Scale Centralized Functional Genomics Initiatives
ENCODE http://www.genome.gov/encode many data types, expanding to developmental brain tissues
Roadmap epigenomics http://www.roadmapepigenomics.org many data types, numerous brain samples
Blueprint epigenome http://www.blueprint-epigenome.eu population level epigenomic data, no brain relevant
samples to date
FANTOM http://fantom.gsc.riken.jp CAGE expression data for limited human brain/neuronal
cell lines
Shen et al., 2012 http://chromosome.ucsd.edu/mouse/download.html mouse ENCODE project as described in Shen et al., 2012
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integration, and whether the readout is image or sequence
based, as reviewed recently (Shlyueva et al., 2014). Beyond as-
saying in vivo activity, reporter assays have been used to docu-
ment the functional autonomy of distal enhancers (Visel et al.,
2009a), changes in enhancer activity due to sequence variation
associated with evolution and human disease (Poitras et al.,
2010; Prabhakar et al., 2008), and to label cells in fate mapping
experiments (Chen et al., 2013; Pattabiraman et al., 2014; Visel
et al., 2013). Reporter-based approaches have been further
adapted to discover new enhancers in the genome (e.g.,
enhancer trappingmethods (Hill andWurst, 1993)), generatemo-
lecular reagents for regional/cell-type specific expression in the
brain (Gong et al., 2003), and used in high-throughput function-
based identification and characterization of enhancers (Arnold
et al., 2013; Dickel et al., 2014; Kheradpour et al., 2013; Murtha
et al., 2014; Patwardhan et al., 2012; White et al., 2013). Similar
methods have been used in simpler and more distant model
organisms, which offer the trade-off of lower cost but larger dif-
ferences in brain anatomy and function compared to humans
(Ariza-Cosano et al., 2012). The combination of single-enhancer
studies that producedetailed spatial and temporalmapsof in vivo
enhancer activity complemented by sequence-based assays of
function have the potential to greatly expand understanding
of regulatory element activity and the effects of regulatory se-
quence variation on brain development. Considering the results
from traditional single gene studies alongside genome-wide or
high-throughput approaches, we next attempt to synthesize cur-
rent understanding of how transcriptional regulation orchestrates
forebrain development, evolution, and function.
TFs Controlling Forebrain Development
Elucidating the transcriptional networks in the developing fore-
brain requires the marriage of defining the cellular and develop-mental functions of individual TFs with their genome-wide
molecular functions. In the telencephalic region of the forebrain
(cerebral hemispheres), this has begun through the identification
of TFs with region and cell-type specific expression patterns.
For instance, telencephalic expression of TFs such as Emx1,
Emx2, Fezf2, Ngn1, Ngn2, Pax6, Satb2, Tbr1, and Tbr2 are
largely restricted to cortically derived glutamatergic progenitors
and neurons (Lai et al., 2013; MacDonald et al., 2013), whereas
Dlx1, Dlx2, Dlx5, Dlx6, Gsx1, Gsx2, Lhx6, Lhx8, and Nkx2-1 are
largely restricted to subcortically derived GABAergic and cholin-
ergic progenitors and neurons (Rubenstein and Campbell,
2013). Note that interneurons of cortical structures (neocortex,
hippocampus, and olfactory bulb) are believed to be largely
generated by subcortical progenitors (Batista-Brito and Fishell,
2013; Rubenstein and Campbell, 2013). Other telencephalic
TFs are jointly expressed by cortical and subcortical regions,
such as Arx, Ascl1 (Mash1), Brn1, Brn2, COUPTFI, COUPTFII,
CTIP1, CTIP2, Cux1, Cux2, Foxg1, Lhx2, Pbx1, Pbx2, Satb1,
Sox5, Sox6, Sp8, and Zfhx1b (Sip1; Zeb2) (Lai et al., 2013; Mac-
Donald et al., 2013; Rubenstein and Campbell, 2013; Ruben-
stein and Rakic, 2013; Thompson et al., 2014), suggesting that
they may share similar functions in both cortical and basal
ganglia development. Many other TFs are likely to be centrally
involved in forebrain development and defining these factors
and their roles is an active area of research. Below we highlight
two signaling pathways active in the developing subcortical
forebrain as examples of how understanding these transcription
factor networks reveals the transcriptional control of neurode-
velopment.
Analysis of Forebrain Development Using TFs Mutants
Many of the TFs involved in forebrain development have been
studied in loss-of-functionmousemutants with the goal to define
their individual and combined in vivo functions (Figure 2). For
instance, analysis of Dlx1/, Dlx2/, Dlx5/, and Dlx6/Neuron 85, January 7, 2015 ª2015 Elsevier Inc. 31
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subsets of neurons in lineages that express theDlx genes (Cobos
et al., 2005; Long et al., 2009a, 2009b; Qiu et al., 1995; Ruben-
stein and Campbell, 2013; Wang et al., 2010, 2011), such as de-
fects in dendrite innervating cortical interneurons (Cobos et al.,
2005; Howard et al., 2014; Mao et al., 2009; Seybold et al.,
2012). On the other hand, the double mutants have earlier and
more pervasive phenotypes that affect regional and cell type
identity, differentiation, and cell migration (Anderson et al.,
1997a, 1997b; Cobos et al., 2007; Wang et al., 2010; Yun
et al., 2002).
Dlx1&2-Associated Network
Systematic analysis by RNA expression arrays and RNA in situ-
hybridization showed that Dlx1/Dlx2/ mice have altered
expression of tens of TFs in the embryonic subpallium (Cobos
et al., 2007; Long et al., 2009a, 2009b). Dlx1/Dlx2/ mice
have overexpression of Ascl1, Gsx1, Gsx2, and Olig2, suggest-
ing that some of the Dlx1&2mutant phenotype is due to overex-
pression of these TFs (Figures 2A and 2C). This hypothesis has
been tested by generating Dlx1&2 triple mutants with Ascl1
(Mash1), Gsx1, Gsx2, and Olig2. For instance, Dlx1&2 promote
neuronogenesis and repress oligodendrogenesis; Dlx1/
Dlx2/ mutants generate excessive oligodendrocytes; this
phenotype is reversed in the Dlx1/Dlx2/Olig2/ triple
mutant, and exacerbated in the Dlx1/Dlx2/Ascl1/mutant
(Petryniak et al., 2007). LikeOlig2,Olig1 represses Dlx-mediated
neurogenesis (Silbereis et al., 2014). Triple mutant analyses also
provided evidence that Dlx1/2, together with Ascl1 and Gsx2,
promote neurogenesis and fundamental subcortical properties,
such as expression of GAD1, the gene encoding the GABA syn-
thesizing enzyme (Long et al., 2009a, 2009b; Wang et al., 2013)
(see Figure 2C for an approach to annotate TF expression
changes in Dlx1/2, Gsx2, and Dlx1/2;Gsx2 mutants).
Dlx1/Dlx2/mutants have reduced expression of a distinct
set of TFs, including Arx, Sp8, and Zfhx1b (Figures 2A and 2C)
(Long et al., 2009b; McKinsey et al., 2013). Analysis of Arx,
Sp8, and Zfhx1b single mutants has given insights into their
individual contributions to the Dlx1/Dlx2/ phenotype. Arx
mutants have a time-dependent block in the maturation and
migration of neurons from basal ganglia progenitor zones (Co-
lombo et al., 2007), similar to Dlx1/Dlx2/ mutants, which
have a progressive accumulation of nonmigrated immature cells
in the subventricular zone (Anderson et al., 1997b; Yun et al.,
2002). Sp8 mutants (Waclaw et al., 2006), as well as Dlx single
and compound mutants (Long et al., 2003, 2007; Qiu et al.,
1995), have olfactory bulb interneuron differentiation defects.
Zfhx1b mutants have abnormal migration of interneurons ge-
nerated by the MGE subcortical progenitor region. Zfhx1b and
Dlx1/Dlx2/ mutants both fail to repress expression of
Nkx2-1 (Figure 2B) (McKinsey et al., 2013; van den Berghe
et al., 2013), a TF that is essential for MGE identity (Sussel
et al., 1999). Nkx2-1 expression needs to be turned off during
maturation of interneurons that migrate to the cortex (No´brega-
Pereira et al., 2008). In Zfhx1b mutants, Nkx2-1 expression per-
sists, leading to an accumulation of MGE-derived interneurons in
the striatum, suggesting that Zfhx1b regulates the switch be-
tween the generation of cortical and striatal interneurons, and
is required for the expression of Maf (cMaf) in migrating cortical32 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.interneurons (Figure 2A) (McKinsey et al., 2013). Furthermore,
there is evidence that Zfhx1b regulates the expression of the
Unc5b receptor, which contributes to the migration defect (van
den Berghe et al., 2013).
Nkx2-1-Associated Network
Nkx2-1 functions in part parallel to the Dlx-driven TF hierarchy
(Figure 2B). Nkx2-1 has a fundamental role in specification of
MGE progenitor cell identity—in its absence, the MGE changes
fate, taking on the more dorsal properties of the LGE and CGE
(Butt et al., 2008; Flandin et al., 2010; Sussel et al., 1999).
Nkx2-1 drives the expression of Lhx6 and Lhx8 (Du et al., 2008;
Sussel et al., 1999), which together with their cofactor Ldb1
(Zhao et al., 2014) are required for the differentiation of
GABAergic (Lhx6) and cholinergic (Lhx8) neurons (Fragkouli
et al., 2005, 2009; Liodis et al., 2007; Zhao et al., 2003, 2008). In-
terneurons lacking Lhx6, have reduced expression of the Arx,
MafB, Npas1, and Sox6 TFs (Figure 2B) (Denaxa et al., 2012;
Zhao et al., 2008) Satb1 function has been linked to activity-
dependent differentiation of cortical interneurons (Close et al.,
2012; Denaxa et al., 2012). Arx function was noted above;
Npas1 represses the generation of a specific set of cortical inter-
neurons (Stanco et al., 2014); Sox6 is required in the MGE to
repress pallial proneural gene expression and to promote inter-
neuron development (Azim et al., 2009; Batista-Brito and Fishell,
2013; Batista-Brito et al., 2009).MafB function in the telenceph-
alon is currently under study. To identify the role of individual
molecules that are downregulated in the Lhx6 mutant, we used
a novel complementation approach (Vogt et al., 2014). For
instance, to test whether reduced Arx expression contributes
to the Lhx6mutant phenotype, lentiviral transduction introduces
Arx downstream of a Dlx1&2 enhancer into dissociated MGE
cells in vitro; these are then transplanted into a wild-type cortex,
and the derived interneurons are phenotyped. In this case,
restoring Arx expression partially restored interneuron expres-
sion of parvalbumin (Vogt et al., 2014).
Mapping TF Function, Combinatorial Activity, and
Genomic Binding in the Forebrain
Thus, even examining these two networks, loss of function ana-
lyses of over 20 TFs have enabled the field to perform detailed
histological, cellular, and molecular analyses of the mutant de-
veloping subpallium and its derivatives, including cortical and ol-
factory bulb interneurons. Similar progress has been made in
defining TF function during pallial development, including its
regionalization and generation of projection neuron subtypes,
although due to space constraints, we will not amplify upon
this important subject (MacDonald et al., 2013; O’Leary et al.,
2013). However, very little is known about how these TFs fit
into the transcriptional circuitry orchestrating such processes,
including the combinatorial activity of TFs. Models based on co-
transcription (Ravasi et al., 2010) and DNase I footprinting (Neph
et al., 2012) to predict co-occurrence of transcription factor bind-
ing sites show that there are robust combinatorial sets of tran-
scription factors that are associated with specific lineages and
tissues, including in the brain. Understanding this combinatorial
functionality of TFs will likely be essential to understanding neu-
rodevelopment. In a functional study of odorant receptor (OR)
regulation in sensory neurons in Drosophila, it was shown via
systematic RNAi-based TF knockdown that combinations of
Neuron
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tion and repression to prevent ectopic expression (Jafari et al.,
2012). This study highlights how combinatorial TF activity via dif-
ferential expression and binding can drive neurodevelopmental
processes and suggests that integrative models of TF activity
will be necessary to understand the complex developmental
architecture of the forebrain. Several additional critical gaps of
knowledge remain to be filled, including identifying all of the
TFs that may participate, the gene regulatory elements (en-
hancers), and the genomic regions where TFs bind.
As noted above, there are now expression databases that
define the spatial and temporal expression patterns of most
TFs (Table 1). Careful annotation of this information, and addi-
tional analyses using RNA expression arrays and RNA-seq in
specific cell types, will greatly facilitate defining the sets of TFs
that are candidates for contributing to TF circuitries. What re-
mains perhaps the largest unmet gap, is the mapping of TFs to
their in vivo genomic binding sites. One method to obtain this in-
formation is ChIP-seq; however, performing TF ChIP-seq on em-
bryonic brain tissue has lagged, in part because the identification
of high-affinity antibodies that specifically bind to a given TF that
is bound to fixed chromatin has been problematic. Nonetheless,
there are examples where inroads have been made. For
instance, there is ChIP-qPCR evidence that DLX2 directly binds
to and regulates the Dlx1&2, Dlx5&6, and Zfhx1b loci (Colasante
et al., 2008; McKinsey et al., 2013; Potter et al., 2009; Zhou et al.,
2004), that NKX2-1 directly binds to and regulates the Lhx6 locus
(Du et al., 2008), and that LHX6 directly binds to and regulates
the Arx locus (Vogt et al., 2014). Genome-wide analyses of
ASCL1 promoter binding in the embryonic brain and in neural
stem cell cultures demonstrated that ASCL1 is bound to pro-
moters of genes regulating cell cycle progression (Castro et al.,
2011). Ongoing studies are now making progress using ChIP-
seq to define the genome-wide landscape of TF binding in the
developing forebrain.
The Regulatory Circuitry Underlying Forebrain
Development
Forebrain Development Is Characterized by Dynamic
Transcription
Analysis of TF expression and effects of loss-of-function in
neuronal stem cell proliferation, differentiation, andmigration, re-
viewed elsewhere (He´bert and Fishell, 2008; Kohwi and Doe,
2013; Molyneaux et al., 2007), have led to models of sequential
or combinatorial expression of TFs in the regulation of these pro-
cesses. The dynamic expression profiles of key TFs are mirrored
by genome-wide transcription patterns generated frommicroar-
rays and more recently, RNA-seq approaches. Transcriptome
analysis of multiple brain regions across multiple developmental
stages revealed extensive regional and temporal differences
(Kang et al., 2011; Miller et al., 2014; Pletikos et al., 2014). These
expression differences coalesce into transcriptional modules of
coexpressed genes that are involved in stage-specific pro-
cesses in specific structures, such as opposing expression pat-
terns of genes associated with neuronal differentiation (at early
stages) and ion channels (at later stages) in the developing
neocortex and hippocampus. To achieve tightly regulated dy-
namic expression profiles, it is likely that cis-regulatory elementsrepresent a substrate for TF binding, enabling precise control via
localization of transcriptional machinery to target promoters,
activate transcription, and recruit chromatin-remodeling pro-
teins that together direct specific spatiotemporal expression of
target genes.
Enhancers Drive Subregional Expression Patterns in the
Developing Forebrain
Gene-centric studies demonstrated that some genes, such as
Arx (Ahituv et al., 2007; Colasante et al., 2008), Dlx1&2, and
Dlx5&6 (Ghanem et al., 2007; Zerucha et al., 2000), have multiple
enhancers with similar activity patterns, raising the possibility
of enhancer redundancy. In addition, some loci (e.g., in the Dlx
family) had multiple enhancers with overlapping, yet distinct
activity patterns, suggesting that a given gene may be regulated
by many enhancers with distinct temporal and spatial activities.
A recent study examined in vivo activity patterns of 145 human
enhancer sequences at high spatial resolution in the mouse
telencephalon at E11.5 using reporter assays and serial histolog-
ical sectioning to generate a digital atlas of enhancer function in
the developing brain (Figures 3A–3D) (Visel et al., 2013).
In addition to generating activity maps for enhancers that are
located nearby genes with key functions in brain development
and neurological disorders, this analysis identified several recur-
rent characteristic features of enhancers active in the develop-
mental brain. First, individual enhancers drove highly reproduc-
ible, spatially restricted enhancer patterns, with large variation
in patterns of expression observed across the sampled en-
hancers that represent all the major subregions of the E11.5
telencephalon (Figures 3A, 3B, and 3D). Generation of stable
transgenic lines for 15 pallial enhancers enabled fate mapping
analysis, showing that enhancers with activity in distinct pallial
progenitor domains generate distinct cortical regions (Pattabira-
man et al., 2014), consistent with the protomap hypothesis
(Rakic, 1988).
Second, when combined to form a composite pattern, the
expression patterns of individual enhancers recapitulate gene
expression patterns as mapped via in situ hybridization, consis-
tent with observations in other organ systems (e.g., Schwartz
and Olson, 1999) that the combined activity of discrete en-
hancer sequences drives complex endogenous gene expres-
sion patterns. For example, four distant-acting enhancer
sequences were described located in the extended locus con-
taining Arx, a gene that regulates pallial and subpallial develop-
ment and is associated with mental deficiency and epilepsy
(Colasante et al., 2008; Friocourt and Parnavelas, 2010; Kita-
mura et al., 2002, 2009; Marsh et al., 2009; Olivetti and Noe-
bels, 2012). Together, these enhancers recapitulate endo-
genous Arx expression (Figure 3C). Third, enhancers that
activated gene expression in the same anatomical structures
were enriched for shared sequence motifs, indicating that high-
ly specific enhancer activity is, at least in part, due to the pres-
ence of binding sites for particular transcriptional regulators
active in the brain. This and other in vivo studies of enhancer
activity in the developing forebrain establish that the cis-regula-
tory landscapes guiding tissue-specific expression patterns are
complex, with the combined action of multiple, sometimes
redundant, enhancers likely involved in regulation of specific
loci.Neuron 85, January 7, 2015 ª2015 Elsevier Inc. 33
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in the Brain
Experiments that characterize neuronal cis-regulation one
element at a time have revealed many aspects of the regulatory
control of forebrain development, yet these studies fail to cap-
ture global patterns of enhancer use and chromatin state during
forebrain development. Early attempts to fill this gap involved
ChIP-seq experiments targeting p300-binding sites in the devel-
opingmouse brain and targeting various histonemodifications in
neuronal cell lineages (Creyghton et al., 2010; Visel et al., 2009b).
More recent genome-wide studies in human and mouse tissues,
including across brain regions, assaying p300 and histone mod-
ifications, DNase hypersensitivity, enhancer [e]RNA, and DNA
hypomethylation are in line with results from in vivo transgenic
assays showing that enhancers are highly tissue-specific (An-
dersson et al., 2014; Shen et al., 2012; Stergachis et al., 2013;
Visel et al., 2007; Zhu et al., 2013).
Two recent studies have directly interrogated temporal
changes in enhancer and epigenomic landscapes by profiling
mouse and human forebrain tissues across developmental
stages. In one approach, ChIP-seq targeting H3K27ac, a histone
modification strongly associated with active enhancers, was
performed on mouse forebrain collected across fetal and post-
natal development (Nord et al., 2013) (Figures 3E–3G). This study
generated in depth maps of enhancer activity in vivo across
development in the forebrain, identifying over 50,000 candidate
enhancers active across development in the forebrain, with the
majority of enhancers predicted to be transiently active. The pre-
dicted activity of a set of enhancers was validated in vivo using
transgenic assays (Figures 3F and 3G). Dynamic enhancer activ-
ity was associated with genes expressed in the control of stage-
specific biological processes such as neuronal proliferation at
early embryonic time points and synapse development and plas-
ticity later. In another time course study, Methyl-seq was per-
formed on cortical tissues from the human and mouse at three
time points to profile dynamic methylation at cytosine residues,
with additional examination of 5-hydroxymethylcytosine in
selected samples (Lister et al., 2013). Hypomethylation was
indicative of enhancer activity, and differentially methylated re-
gions were detected that indicate extensive turnover in enhancer
activity consistent with the H3K27ac signatures observed in
the developing mouse brain. As further evidence of the dynamic
activity of enhancers in the developing brain, comparison of
embryonic stem cells, neural stem cells, and neural progenitors
showed that enhancer-promoter interactions are specific to
each cell population (Zhang et al., 2013). In a finding suggestiveFigure 3. Spatial and Temporal Specificity of Enhancers Active in the D
(A) Subset of forebrain enhancers with a spectrum of subregional specificities at
(B) Examples of enhancers with restricted pallial activity in the mouse telenceph
(C) Multiple enhancers in the larger region surrounding the Arx gene show sub
expression in the mouse forebrain. Notably, enhancer activities show partial spa
(D) Example of an enhancer with activity across multiple developmental stages,
MGE, through the LGE, to the cortex (white arrows).
(E) Developmental dynamics of enhancer-associated histone mark H3K27ac at
brain development. Most sites show temporally restricted H3K27ac marks.
(F and G) Examples of in vivo validated temporally dynamic enhancer activity in
choroid plexus; Cx, cortex; CxP, cortical plate; DP, dorsal pallium; LGE, lateral ga
medial pallium; MZ, marginal zone; VP, ventral pallium.
(A)–(D) modified from Visel et al. (2013); (E)–(G) modified from Nord et al. (2013).of how some noncoding regions act to control lineage speci-
fication, it was recently observed that there are large domains
exhibiting chromatin modifications consistent with regulatory
sequence that are particularly responsive to essential lineage
specification or pluripotency factors. These loci, referred to as
‘‘super-enhancers’’ (Chapuy et al., 2013; Hnisz et al., 2013;
Whyte et al., 2013) or ‘‘stretch enhancers’’ (Parker et al., 2013)
have been predicted to exist in brain tissues as well, with initial
analysis suggesting that TFs such as NKX2-2, OLIG1, BRN2,
SOX10, and SOX2 are master regulators that interact with these
regulatory regions in the brain (Hnisz et al., 2013). It is unclear
whether these larger domains represent regulatory elements
that act in a cooperative way that is qualitatively different from
enhancers as previously described, or if they instead are simply
regions that are densely packed with regulatory sequences.
In parallel to gene activation, cis-regulatory sequences and
chromatin state are also involved in the repression of transcrip-
tion. Specific TFs can have activating or repressing effects
depending on context. For example, REST/NRSF is a master
regulator of neurogenesis that acts to repress transcription of
neuronal genes in nonneuronal lineages by recruiting chromatin
remodeling proteins (Ballas et al., 2005). Major markers of
repressive remodeling in the brain include H3K27me3 and DNA
hypermethylation at gene bodies and distal enhancers (Lister
et al., 2013; Zhu et al., 2013). Likely due to extensive repressive
chromatin in intergenic regions and nonexpressed genes in
mature neuronal lineages, the majority of enhancers active in
the adult brain were found within gene bodies of neuronal genes
or near the transcription start site in two independent studies
(Nord et al., 2013; Zhu et al., 2013). These studies indicate that
chromatin state dynamics are an important factor in brain devel-
opment, a finding paralleled by recent studies of neurodevelop-
mental disorders discussed below.
Enhancers as Tools for Analysis of Forebrain
Development
Enhancer elements generally maintain correct temporal-spatial
control when ectopically positioned in the genome (e.g., (Gha-
nem et al., 2007; Visel et al., 2013; Zerucha et al., 2000)). Thus,
these elements canbe used experimentally to drive spatiotempo-
rally restricted gene expression in specific brain regions and cell
types. For instance, enhancers driving Cre expression have been
used for fate mapping experiments of the subpallium (Potter
et al., 2009; Waclaw et al., 2010) or pallium (Pattabiraman et al.,
2014). Figure 4 illustrates the use of an enhancer (hs636) with ac-
tivity in ventral parts of the pallial primordium (GFP expression
in Figure 4D, schematically summarized in Figure 4C) to fateeveloping Forebrain
whole-mount resolution.
alon at E11.5.
regional forebrain activity patterns that recapitulate endogenous Arx mRNA
tial redundancy.
labeling cell populations whose location is consistent with migration from the
candidate forebrain enhancers analyzed by ChIP-seq across seven stages of
the forebrain, as predicted by temporally dynamic H3K27ac signatures. CP,
nglionic eminence; LP, lateral pallium; MGE, medial ganglionic eminence; MP,
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Figure 4. Enhancers as Tools for Analyzing Forebrain Development
(A) PAX6 ChIP-seq analysis from E12.5 cortex showing a peak directly over endogenous enhancer 636 (black bar).
(B) GFP pallial expression driven by enhancer hs636 in E11 cortex and reduced pallial GFP expression in Pax6/.
(C) Schema showing approximate position of GFP expression (red) within flattened view of E11.5 pallial progenitor zones.
(D) Enhancer hs636 activity in E10.5 telencephalon in stable transgenics (yellow arrowheads: ventrolateral pallial neurons; red arrowheads: ventrolateral pallial
progenitors 24127591).
(E and F) Fate mapping using enhancer hs636. Cre recombination was tamoxifen-induced at E9.5 and brains were analyzed at E17.5 for tdTomato staining (F).
Results are summarized in a schematic map showing dtTomato expression within a flattened view of E17.5 pallial subdivisions, color-coded according to
approximate density of tdTomato+ cells (E).
(A)–(F) modified from Pattabiraman et al. (2014). Abbreviations according to region: ventral pallium (VPall, allopallium): AO, anterior olfactory nuclei; OB, olfactory
bulb; Pir/EPir, piriform and ectopiriform; LERh, lateral entorhinal; MERh, medial entorhinal. Lateral pallium (LPall, mesopallium): Ins/Cl, insula/claustrum; LO,
lateral orbital; PRh, perirhinal; Orb, orbitofrontal. Dorsal pallium (DPall; neopallium): AU (A), auditory; DPF, dorsal prefrontal; F, frontal; LPF, lateral prefrontal; M,
motor; SS, somatosensory; V, visual. Dorsomedial pallium (DMPall): Cing (C), cingulate gyrus; IL, infralimbic (and PrL, prelimbic); MOrb, medial orbital; RSP,
retrosplenial; PoRh, postrhinal. Medial pallium (MPall): CA1-3, CA fields 1–3; DG, dentate gyrus; fi (F), fimbria; IG, indusium griseum; Sub (S), subiculum; PaS,
parasubiculm; PrS, presubiculum; TT, tenia tecta. Dorsal midline: bac, brachium of the anterior commissure; bcc, brachium of the corpus callosum; bhc,
brachium of the hippocampal commissure; ch, choroid plexus; PSe (PS), pallial septum. Pallial amygdala (Pall Amygd): AA, anterior amygdala; Ahi, amygda-
lohippocampal area; BM, basomedial; BLA, basolateral; LA, lateral. Subpallium: Acb, accumbens; CGE, caudal ganglionic eminence; Dg, Diagonal area; LGE,
lateral ganglionic eminence; MGE, medial ganglionic eminence; Pal, pallidum; SPSe, subpallial septum; St, striatum. Hypothalamus: hp1, 2, hypothalamic
prosomere 1 and 2; PHy, peduncular; Thy, hypothalamus. Diencephalon: Hb, habenula; p2, p3, prosomeres 2 and 3; Thy, terminal hypothalamus; PThE, pre-
thalamic eminence; Th, thalamus.
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Figure 5. Insights and Challenges in
Deciphering the Regulatory Architecture of
Forebrain Development
(A) Comparative functional genomic studies, such
as large-scale studies of gene expression patterns
in the developing brain by RNA in situ hybridiza-
tion, provide insight into general and human-spe-
cific aspects of molecular pathways involved in
brain development.
(B) Comparative genomic studies reveal a deeply
conserved regulatory framework associated with
brain development, but can also identify specific
changes in regulatory sequences that underlie
structural and functional innovations in the brain
observed in vertebrate evolution. Remarkably,
regulatory sequences active during early stages of
brain development (midgestation inmouse) tend to
be under higher evolutionary constraint than those
active later in development and in the adult brain.
(C) Genome-wide association, exome sequencing,
copy number variation, and whole-genome se-
quencing studies of patient cohorts are powerful
tools for identifying genes and noncoding se-
quences associated with neurodevelopmental
disorders. These studies have revealed a major
role for proteins involved in chromatin remodeling,
DNA methylation processes, histone modification,
and other transcriptional regulatory pathways and
processes, with individual genes reported in hu-
man genetic studies offered as examples.
(D) Systems-level analysis integrating expression,
genetic, epigenomic, and functional data has the
potential to elucidate genetic and functional net-
works required for normal brain development and
function, which are thought to be disrupted in
neurodevelopmental and neuropsychiatric disor-
ders.
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Reviewmap its derivatives (Cre-mediated induction of tdTomato expres-
sion in Figure 4F, schematically summarized in Figure 4E).
Enhancer hs636 is bound by PAX6 in vivo (Figure 4A), and de-
pends on Pax6 function for its expression (Figure 4B). Enhancers
driving markers such as GFP can be used in stem cell differenti-
ation experiments to indicate when particular telencephalic cell
states differentiate and for cell purification using FACS (Chen
et al., 2013). Given their small size, they can also be used in viral
vectors to confer cell type-specific gene expression, and have
recently been used to drive expression in cortical interneurons
(Lee et al., 2014; Vogt et al., 2014).
Evolutionary Conservation and Novelty of Gene
Regulation in the Brain
Ongoing studies of various vertebrate species, including human,
are defining the transcription factors and enhancers that control
cortical development (Miller et al., 2014; Shim et al., 2012). These
analyses are expected to shed light on the genetic mechanisms
that have contributed to cortical evolution and disease (Willsey
et al., 2013). Comparative transcriptomic analyses have demon-
strated differences in expression of genes in the developing
brain across primates (Khaitovich et al., 2004; Konopka et al.,
2009; Nowick et al., 2009) and between mice and humans (MillerNeuronet al., 2014) (Figure 5A). Evolutionary dif-
ferences in the structure and represen-
tative cell types and connectivity of the
forebrain are observed across verte-brates, with the six-layered laminar structure arising in mammals
and the expansion in cortical surface area producing complex in-
volutions observed in a number of species, including humans.
These differences may be associated with changes in the
expression patterns of and the interactions between specific
transcription factors in the developing brain. Studies on the evo-
lution of regulatory control systems and cis-regulatory elements
have produced paradoxical findings highlighting both extreme
evolutionary constraint and human-specific regulatory changes
as strong forces in shaping the forebrain. King and Wilson
demonstrated high levels of coding sequence conservation be-
tween human and chimpanzee and postulated that noncoding
changes account for the majority of sequence level differences
between the species (King and Wilson, 1975). The availability
of sequenced genomes has enabled comparisons of noncoding
sequence homology across the vertebrate evolutionary tree and
recently, between humans and extinct hominins (Green et al.,
2010). Perhaps surprisingly, very high levels of sequence conser-
vation have been observed at regulatory sequences active in the
developing forebrain across the vertebrate lineage, with ultra-
conserved regulatory elements enriched for forebrain activity in
transgenic assays compared to other tissues in E11.5 mice85, January 7, 2015 ª2015 Elsevier Inc. 37
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brain enhancers relative to other tissues (Blow et al., 2010; Nord
et al., 2013; Pennacchio et al., 2006). Interestingly, the level of
constraint on stage-specific forebrain enhancers decreases
significantly from midgestation to adult (Nord et al., 2013)
(Figure 5B), a pattern also observed across various develop-
mental lineages (Bogdanovic et al., 2012; Stergachis et al.,
2013). This pattern is observable in the constraint of gene
expression patterns and general morphology (Domazet-Loso
and Tautz, 2010; Kalinka et al., 2010; Quint et al., 2012), in line
with the hourglass model of evolutionary constraint on develop-
ment (Casci, 2011). Further supporting the conservation of
neuronal regulatory networks, a study of transcription factor co-
expression and interaction comparing human and mouse identi-
fied a number of transcription factor networks that appear
conserved between mouse and human in the developing brain
(Ravasi et al., 2010). These findings suggest that cis-regulatory
landscapes controlling early forebrain development are gener-
ally relatively ancient.
Despite the observation of strong evolutionary constraint at
brain enhancers, other studies examining sequence and func-
tional conservation of enhancers suggest that human regulatory
elements exhibit high levels of evolutionary innovation both in
sequence and function. One locus that has been examined in
detail is AUTS2, a gene implicated in human evolution and
in neurological disorders. Sequence comparisons at this locus
between human and Neanderthal genomes identified one of
the strongest signals for human-specific noncoding sequence
changes (Green et al., 2010), and noncoding sequences at this
locus exhibiting human-specific changes drove expression in
the developing brain (Oksenberg et al., 2013). A second
approach has been to look for regulatory regions that have
high levels of evolutionary constraint but where there are hu-
man-specific changes, also known as human-accelerated re-
gions (HARs) or accelerated conserved noncoding sequences
(aCNSs), or where there is no mappable human homolog
(McLean et al., 2011; Pollard et al., 2006; Prabhakar et al.,
2006a). HARs and aCNSs are enriched near TFs and near genes
associated with neuronal cell adhesion and human-specific de-
letions are similarly associated with neural functions, findings
suggestive of sequence-level changes that drive human-specific
aspects of brain development. Genome-wide comparison of
functional conservation of enhancers as assayed by p300 inter-
action revealed evidence that sequences exhibiting significant
homology between human and mouse can show functional dif-
ferences in the developing brain. This comparison only included
a single developmental time point at which mouse and human
brains should be relatively stage matched (Clancy et al., 2007)
and candidate enhancers identified using only a single epige-
nomic mark (Visel et al., 2013), and further experiments are
necessary to elucidate functional conservation across tissues
and developmental stages. While not in a neuronal tissue, recent
work comparing functional conservation using epigenomic as-
says in hepatocytes (Odom et al., 2007) and developmental
limb tissue (Cotney et al., 2013) demonstrate significant lack of
functional conservation between humans and other vertebrate
lineages. These findings are supported by functional enhancer
assays comparing activity in Drosophila lineages (Arnold et al.,38 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.2013). Finding of limited functional conservation of noncoding el-
ements in the brain is in line with studies directly comparing TF
binding and H3K27ac across evolution in other tissues, which
suggest substantial turnover in TF binding sites and evolution
of new enhancers via functional modification or co-option of en-
hancers active in other tissues (Lettice et al., 2011; Schmidt
et al., 2010; Stefflova et al., 2013). Annotated maps of human
forebrain enhancers will be required to determine the balance
between evolutionary conservation and innovation in cis-regula-
tory control of human forebrain development.
Gene Regulation and Neurodevelopmental Disorders
Loss of Function of Regulatory Genes in Forebrain
Development
Mouse knockout models are now available for thousands of
genes, including many genes known or proposed to be involved
in transcriptional regulation during brain development. Studies
using these models have revealed severe neuroanatomical con-
sequences and frequently embryonic lethal phenotypes associ-
ated with loss of function of neuronal transcriptional regulators,
as described above. In parallel, some of the first successful ef-
forts to map human monogenic neurodevelopmental disorders
implicate transcriptional regulation and chromatin remodeling
in synapse development and plasticity, such as MECP2 in Rett
syndrome and FMR1 in fragile X syndrome (Amir et al., 1999; Ver-
kerk et al., 1991). A growing body of evidence supports that mul-
tiple human neurodevelopmental disorders are associated with
mutations in TFs, including Arx, Pax6, Six3, and Tbr1 (Bhatia
et al., 2013; Hehr et al., 2010; Olivetti and Noebels, 2012; van
Heyningen and Williamson, 2002; Willsey et al., 2013).
Human Genetic Studies of Forebrain Transcriptional
Regulation
There has been a leap forward in understanding the genetic com-
ponents of complex neurodevelopmental disorders in recent
years (McCarroll and Hyman, 2013). While the relative contri-
bution to these traits across the spectrum of allele frequency
remains an active discussion (McClellan and King, 2010), repli-
cated findings at specific loci have established a role for both
common and rare variants via genome-wide association studies
(GWAS), rare or de novoCNV screening, and exome sequencing,
as reviewed recently (Krystal and State, 2014; McCarroll and Hy-
man, 2013). The findings from human genetics studies point to
polygenicity and a significant role for genes involved in transcrip-
tional regulation and chromatin remodeling in the developing
forebrain in the etiology of disorders such as autism, schizo-
phrenia, and intellectual disability (Figure 5C). Studies of autism
and schizophrenia have highlighted pathways required for tran-
scriptional regulation and chromatin remodeling, as well as other
functional classes, such as calcium channels and synaptic plas-
ticity genes (Krystal and State, 2014; McCarroll and Hyman,
2013). Evidence is mounting for dosage effects or haploin-
sufficiency of developmental TFs, such as TBR1, and chromatin
remodeling proteins, such as CHD8, as a mechanism in these
disorders (O’Roak et al., 2011, 2012a, 2012b). It is also likely
that regulatory sequence variation contributes to these traits
because regions around many of the replicated GWAS signals
as well as rare disease-associated CNVs do not contain coding
sequence variants. Furthermore, disease-linked variants have
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that result in changes in enhancer activity (Poitras et al., 2010).
Transcriptional Regulation and Chromatin Remodeling
in Autism and Schizophrenia
While there are now many genes identified via rare and de novo
CNV screening and exome sequencing, it will take larger
screening efforts and functional follow-up to establish the causal-
ity and pathophysiology of thesemutations. An approach to learn
more about these networks that has yielded success for autism
and schizophrenia is to identify brain subregions and develop-
mental stages at which the implicated gene networks are coex-
pressed using publicly available brain transcriptome data (Kang
et al., 2011) (Figure 5D). In autism, coexpression networks pre-
sent in midfetal layer 5/6 cortical projection neurons were identi-
fied that were organized around high-confidence ‘‘seed’’ genes
that are mutated in autism (Willsey et al., 2013). A similar study
linked rare de novo coding mutations in autism to coregulated
highly expressed genes during early neuronal fate determination,
migration, and establishment of the cortical layers, providing
suggestive evidence of a gene set that contributes to autism
via haploinsufficiency (Parikshak et al., 2013). The same study
identified glutamatergic neurons in superficial cortical layers
(layer 2–4) as a potential cell type where autism-associated
expression networks may be critical. These two studies describe
different specific cortical layers as relevant, but the develop-
mental regulatory processes affected by both sets of gene
network analyses are highly convergent. An earlier study of
gene expression in autism-associated cortical regions from
autistic subjects versus controls identified differentially ex-
pressed genes and expression networks in autism,with a number
of genes that overlap the two recent studies (Voineagu et al.,
2011). A study examining de novo mutations in schizophrenia
linked genes with predicted deleterious coding mutations in
cases to expression networks in the fetal dorsolateral and ventro-
lateral prefrontal cortex (Gulsuner et al., 2013). While a complex
combination of genetic and environmental factors is likely to
influence these phenotypes, these studies illustrate how human
genetic studies in tandem with functional genomics data can
reveal the pathophysiology of neurodevelopmental disorders
and the causal role that loss of endogenous gene expression
and transcriptional regulatory circuits during brain development
plays.
Knockout Models of Enhancer Function
Noncoding sequence variation is predicted to represent a sub-
stantial proportion of disease-associated variants (ENCODE
Project Consortium, 2012), yet the requirement for specific en-
hancers during development remains largely unclear. There are
examples of sequence variation at enhancers that are linked to
developmental phenotypes, with one of the most well-known
instances being mutations in the ZRS enhancer of Shh that
lead to limb malformations (Lettice et al., 2003). There are a
few examples of enhancers whose deletion was shown to cause
clear neurodevelopmental phenotypes. For instance, deletion of
an enhancer regulating Fezf2 resulted in loss of Fezf2 expression
and anatomical changes in the brain characterized by loss of
specification of corticospinal neurons (Shim et al., 2012). On
the other hand, a study that targeted four ultraconserved
enhancers, which included enhancers predicted to regulatebrain-expressed genes that produced severe phenotypes
when knocked out, found that mice homozygous for the en-
hancer deletion allele for each of the four enhancers did not
have gross neurodevelopmental or neurological phenotypes
(Ahituv et al., 2007), indicating that even the evolutionarily most
conserved enhancers may not necessarily have functions at
the organism level that that are required for viability.
Two related explanations may account for the mixed conse-
quences of enhancer loss of function in these mouse models.
The first is that there is a high level of functional redundancy in
enhancers that regulate a specific locus. In this model, loss of
function of a single enhancer is masked by the activity of another
enhancer that drive a similar expression pattern, as has been
observed for ‘‘shadow’’ enhancers in Drosophila (Lagha et al.,
2012). In a similar model, enhancers may not be functionally
redundant, but they act in a combinatorial manner where each
enhancer acts to fine tune the expression of a gene. In this
model, careful phenotyping would be necessary to identify the
changes caused by loss of enhancer function. Outside the brain,
this general paradigm was recently demonstrated in a study
where deletions of craniofacial enhancers produced subtle
morphological changes (Attanasio et al., 2013). While there
remain a small number of regulatory loss-of-function models in
mouse, results from human genetic studies, especially GWAS,
suggest a significant role for regulatory variation across pheno-
types, including in neurodevelopmental disorders (Ripke et al.,
2013). It is quite possible that each regulatory circuit will be
different, with strong effects possible for loss of function at
some enhancers and weak or no observable phenotypes seen
when other enhancers are deleted or when sequence variation
changes enhancer activity.
Conclusions and Major Outstanding Questions
The combination of detailed functional dissection of the roles of
individual TFs with genome-wide approaches to mapping gene
expression, enhancer activity, and chromatin dynamics reveal
an emerging picture of the role of transcriptional regulation in
forebrain development. These studies link cell-specific expres-
sion of TFs during processes such as proliferation, differentia-
tion, migration, and synapse development to target genes via
binding at TF binding motifs found in promoter-proximal se-
quences and distal enhancers. These regulatory circuits are
emerging as tightly linked to the evolution of the human brain
and to human neurodevelopmental disorders, with initial indica-
tions of specific developmental cortical subregions and neuronal
classes that may be affected by mutations that contribute to dis-
orders such as autism and schizophrenia. Figure 5 summarizes
findings from recent studies highlighting the role of gene regula-
tion in evolution and neurodevelopmental disorders.
With the availability of new technologies for epigenomic and
functional profiling of regulatory sequences, availability of pa-
tient-specific models such as induced pluripotent stem cells
and precision-engineered animal models, where is the field
headed?We nowdiscussmajor challenges for three areas: basic
biological mechanisms underlying gene regulation, the role of
regulatory elements and chromatin structure in brain develop-
ment, and linking findings from human genetic studies to biolog-
ical mechanisms focusing on gene regulation.Neuron 85, January 7, 2015 ª2015 Elsevier Inc. 39
Neuron
ReviewChallenge 1: Basic Mechanisms
General models of gene regulation via TF binding and activation
or repression through cofactor recruitment, changes in chro-
matin accessibility, and DNA looping are becoming clearer, yet
many of the basic mechanisms required for this process are still
poorly defined. TF binding sites can be predicted based on
various experimental methods and can be validated using direct
measures of interaction; however, it appears that a large pro-
portion of the validated binding sites of many TFs may not be
functionally relevant (White et al., 2013), and that combinatorial
binding of TFs may govern function (Teng et al., 2014). Consis-
tent with these observations, levels of individual TF expression
do not have extensive global effects as measured by TF knock-
down and expression profiling (Cusanovich et al., 2014). There
are additionally unresolved questions regarding regulatory func-
tion and the balance of conservation versus binding site turnover
within enhancers across evolution (Villar et al., 2014), the order
and spacing of binding sites within enhancers (Smith et al.,
2013), the requirement for specific TF binding interactions within
enhancers (Teng et al., 2014), and the relationship between
structural contact through looping and transcriptional activation
(DeMare et al., 2013; Kieffer-Kwon et al., 2013).
A second major mechanistic question is how enhancers drive
expression of a specific gene or set of target genes given the
observation that many enhancers appear to skip nearby tran-
scription start sites to interact with more distal targets (Zhang
et al., 2013). Although recent advances mapping chromatin in-
teractions enable mapping of enhancer-promoter interactions,
the mechanism for establishing specificity has been studied
only for a very small number of loci. It is clear that enhancers
vastly outnumber their transcribed targets. Themodel of specific
enhancers driving cell-type or tissue-specific expression pat-
terns is attractive and is true at a genomic scale, yet it appears
that many genes are controlled by complex landscapes of
potentially redundant regulatory elements and that loss of func-
tion of even highly conserved enhancers near critical genes may
not produce significant phenotypic effects (Ahituv et al., 2007).
Recent studies suggest that enhancer redundancy is required
to maintain robust expression patterns (Lagha et al., 2012) and
that arrays of regulatory elements with correlated activity may
enable tighter quantitative or qualitative regulation of expression
(Whyte et al., 2013); however, this remains a relatively unex-
plored area especially in mammalian systems.
At this time, no single known epigenomic signature is sufficient
to identify all enhancers and distinguish enhancers that are
active with perfect specificity (Cotney et al., 2012), and an active
area of research is honing prediction algorithms that are based
on regulatory sequence composition, epigenomic signatures,
and genomic structure, and in developing methods to enable
function-based screening of regulatory element activity as
described above. A central assumption to the current models
is that the census of TFs present combined with the relevant reg-
ulatory sequence substrate represents the information neces-
sary for interpreting endogenous enhancer function, yet the field
remains a long way from determining the rules that govern the
processes involved in the establishment and function of
mammalian regulatory circuitry and in predicting the effects of
perturbations to these systems.40 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.Challenge 2: GeneRegulation in Forebrain Development
The framework and major actors in many TF signaling networks
active in control of differentiation across a variety of neuronal
subtypes are becoming clearer, with emerging Dlx1/2 and
Nkx2-1 networks in the LGE/CGE/MGE detailed above. How-
ever, these existing pictures are likely to represent a gross
simplification of the intrinsic and external factors directing devel-
opmental processes in the brain. Moving from single genes to
networks will require systems level analysis of brain develop-
ment. Efforts are already underway to map the transcriptome
(Kang et al., 2011; Miller et al., 2014) and connectome (Oh
et al., 2014) of developing brains, and significant resources will
be developed toward developing new technologies. Genomic
analysis has led the way, with major accomplishments using
RNA-seq to understand transcriptional differences underlying
normal and pathogenic brain development (Kang et al., 2008;
Miller et al., 2014; Voineagu et al., 2011). In the future, the direct
and indirect regulatory interactions that drive brain development
will be revealed at a systems level with the level of rigor and detail
that is currently only possible via in depth examination of individ-
ual circuits.
In contrast to the substantial effort dedicated to mapping TF
activity in the developing brain, other aspects of the regulatory
circuitry orchestrating normal and pathogenic neurodevelop-
mental processes remain underexplored. While genome-wide
studies have established that the dynamic activity of tens of
thousands of enhancers orchestrates spatiotemporal gene
expression in forebrain development, mapping and epigenomic
and functional characterization of these elements in the human
genome remains a priority. Furthermore, technology exists to
establish enhancer-promoter interactions (Fullwood and Ruan,
2009; Lieberman-Aiden et al., 2009), which will be critical to un-
derstanding the control of loci involved in specific processes or
implicated in specific disorders. Of the tens of thousands of en-
hancers predicted in functional genomics studies of brain devel-
opment, only a fraction of the target genes have been predicted
with experimental confirmation of required regulatory activity
available for only a small subset of these predictions (e.g.,
Shim et al., 2012). It is unlikely that current centralized efforts
will have the bandwidth to profile all of the multidimensional
axes of brain subregions, temporal stages across differentiation
and development, and the different lineages represented in the
brain. Nonetheless, the technology required to map and charac-
terize regulatory elements is accessible and individual research
groups can now profile specific systems of interest. Through
these combined efforts, a more complete picture of the location,
function, and targets of neural regulatory elements should
emerge.
Complementary to characterizing the activity of individual reg-
ulatory elements genome-wide across the multidimensional
space of brain development is the less studied role of chromatin
remodeling and epigenetic marking in brain development. Early
studies in this area suggest a central role for chromatin remodel-
ing factors in forebrain development, substantial transcriptional
control via chromatin restriction as lineage specification pro-
ceeds in the brain, and widespread changes in DNA methylation
patterns across brain development (Lister et al., 2013; Ronan
et al., 2013; Zhu et al., 2013). Further studies are necessary to
Neuron
Reviewunderstand themechanism and requirement for these processes
in neurodevelopment. Finally, the availability of genomic data
sets, functional genomic assays, and efficient genomemodifica-
tion technology will enable deeper exploration of the regulatory
circuits and activities of specific TFs in brain development.
With new technologies for precision genome engineering
emerging (Bedell et al., 2012; Christian et al., 2010; Jinek et al.,
2012; Mali et al., 2013), we foresee rapid expansion in the under-
standing of the interplay of specific genes that control neural
lineage specification, regionalization, and function. Through the
results of these studies, it will be possible to ask more detailed
questions regarding the role of regulatory sequences and chro-
matin remodeling processes in the development and function
of the brain and potentially in the role of noncoding sequence
in the evolution of the human brain and cognitive capacity.
Challenge 3: Gene Regulation in Neurodevelopmental
Disorders
As described above, neurodevelopmental disorders appear to
be driven in part by changes in gene expression levels during
development, highlighted by the dosage sensitivity observed in
genes identified by CNV and exome screening. The compelling
evidence generated by recent attempts to intersect neurodeve-
lopmental transcriptome data with genes linked to autism and
schizophrenia is, as of now, more suggestive than conclusive
regarding the pathophysiology of these disorders (Parikshak
et al., 2013; Voineagu et al., 2011; Willsey et al., 2013). Further
work is required to map the affected cell types and document
the molecular changes and cell biology associated with changes
in expression of susceptibility genes. Additionally, there are two
major unexplored potential driver mechanisms behind neurode-
velopmental disorders. First is the effect of noncoding sequence
variation. As regulatory elements are predicted to direct robust
expression patterns in the developing brain, it is likely that
sequence variation that changes the function of these elements
has the potential to drive changes in gene expression and down-
stream dosage-sensitivity-driven effects. Although many GWAS
have identified noncoding regions as associated with pheno-
types such as autism and schizophrenia, the causal variants
have yet to be characterized. In a recent example of a large effect
noncoding variant with severe phenotypic consequences in the
brain, a short deletion in regulatory sequence was identified in
subjects exhibiting gyral abnormalities (Bae et al., 2014). The
deletion variant disrupted the regulatory function, leading to a
change of expression of isoforms of GPR56 and resulting in
changes in the cortical expression pattern of this gene, which re-
sulted in restricted polymicrogyria surrounding the Sylvan fissure
that is linked to intellectual and language difficulty and seizures.
Another suggestive finding is the duplication of the region con-
taining VIPR2 in schizophrenia, where a minimal duplication of
noncoding sequence was observed in cases (Vacic et al., 2011).
The current list of characterized causal variants found in non-
coding regions appears exceptionally small when viewed in light
of the current prominence and success of screening coding
sequence (e.g., exome sequencing). In the future, whole genome
analysis will enable unbiased examination of noncoding se-
quences as well, but there will be major challenges connected
to the expected large number of variants and the difficulty of pre-
dicting functionality of affected noncoding sequence (Jianget al., 2013). The expansion of regulatory element mapping and
characterization described above will enable screening of non-
coding regions. In the meantime, targeted examination of non-
coding regions may be a viable intermediate approach, where
predicted functional or conserved noncoding elements around
susceptibility genes could be screened at a volume sufficient
to start to dissect differences between case and control popula-
tion variation at these loci.
An area poised for large-scale growth in the near future is the
characterization of epigenomic or epigenetic changes in the
brain (or in induced pluripotent stem cell-derived differentiated
neurons) of individuals afflicted with neurological and neurode-
velopmental disorders. These studies are confounded by the dif-
ficulty of assigning causal relationships for observed differences
in driving original pathophysiological processes or in contrib-
uting to later manifestations of the traits. Nonetheless, the emer-
gence of consistent patterns associated with specific pheno-
types has the potential to provide evidence for a role of stable
epigenetic changes that will ultimately lead to better understand-
ing of the forces contributing to neurodevelopmental disorders
and could provide a link between environmental factors and
long-term changes in gene regulation.
The identification of specific regulatory elements or of wide-
spread epigenetic changes will additionally generate novel tar-
gets for therapeutic intervention. Already, major changes are
underway in the molecular diagnosis of neurodevelopmental
disorders that enable better clinical care (Krystal and State,
2014), as well as the development of promising targeted thera-
peutic approaches (Gross et al., 2012). The ability to target the
CRISPR/Cas9 or TALE systems to specific sequences has been
harnessed to build synthetic regulatory proteins that can act to
change gene expression or epigenomic markings at specific
regulatory elements (Mendenhall et al., 2013). In the not-too-
distant future, it may be possible to use synthetic regulators
to modify gene dosage of target genes involved in key pro-
cesses in specific neuronal cell populations implicated via
studies of transcriptional regulation in normal and pathogenic
brain development. With the combination of new technologies
and the rapidly growing understanding of the role of transcrip-
tional regulation in neurodevelopment, this is an exciting and
rapidly changing field that has the potential to transform our un-
derstanding of the evolution, development, and function of the
human brain.
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